ResQ1010

· ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ResQ1010, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: ResQ1010-NSCLC: NAI + Chemoimmunotherapy vs Chemoimmunotherapy for First-Line Advanced/Metastatic NSCLC [Phase 3]